Real-world evidence now supports new indications and safety decisions, and AI increasingly generates it. Boards should know where their company relies on it, how well the design fits the question, and how its credibility is shown.

Most acquisitions that disappoint fail for reasons that were visible before the vote. The board does not need to run the tools that expose them; it needs to see what the tools found before it approves the deal.